Hypertension accounts for a massive and growing proportion of healthcare spending in Canada, highlighting the economic imperative for effective prevention and treatment strategies.
No takes yet. Share an insight, caveat, or question.
Hypertension-attributable costs reached $1.4B in Alberta in 2010 with doubling projected by 2020; leaves open the effect of interventions on future burden.
Weaver et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: